Cholinesterase inhibitors may produce small improvements in cognitive functioning in patients with mild cognitive impairment (MCI) but do not appear to benefit global functioning, according to the results of a new multicentre, randomized trial (Doody et al. Neurology 2009; epublished January 28, 2009).